ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Food and Chemical Toxicology
Volume 45, Issue 3, March 2007, Pages 508-514
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (511 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.fct.2006.08.013    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier Ltd All rights reserved.

Brief communication

Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme

Wolfgang Bednara, Klaus Holzmanna and Brigitte MarianCorresponding Author Contact Information, a, E-mail The Corresponding Author

aDepartment of Internal Medicine 1, Institute of Cancer Research, Medical University Vienna, Borschkegasse 8a, 1090 Vienna, Austria

Received 30 January 2006; 
accepted 14 August 2006. 
Available online 30 August 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

12(S)-Lipoxygenase (LOX) is regarded as a pro-tumorigenic enzyme and as a potential target for therapy and prevention of cancer so that the search for specific 12(S)-LOX inhibitors is part of drug development strategies. To facilitate the identification of specific 12(S)-LOX inhibitors we have created an assay cell line by introducing a12(S)-LOX expression vector into SW480 colorectal cancer cells. When arachidonic acid was supplied in the medium both transiently and stably overexpressing cells produced 12(S)-hydroxytetraenic acid (HETE) originating from the transfected gene at 4–5-fold the amount obtained from control transfectants. 12(S)-HETE production was 1913.7 ± 17.2 pg/ml and reached a steady state level 24 h after addition of arachidonic acid. To demonstrate the models suitability of 12(S)-LOX overexpressing SW480 cells they were used to measure the inhibitory activity of the plant phenols baicalein, kaempferol, quercetin, nordihydroguaretic acid and resveratrol which are known for their chemopreventive as well as LOX-inhibitory activity in different tumour models. All 5 compounds inhibited 12(S)-HETE production at concentrations below those necessary for growth inhibition.

Keywords: 12(S)-Lipoxygenase; 12(S)-HETE, ELISA

Abbreviations: AA, arachidonic acid; CDC, cinnamyl-3,4-dihydroxy-α-cyanocinnamate; COX, cyclooxygenase; FCS, foetal calf serum; FACS, fluorescence activated cell sorter; GFP, green fluorescence protein; HETE, hydroxytetraenic acid; LOX, lipoxygenase; MEM, minimal essential medium; PG, prostaglandin

Article Outline

1. Introduction
2. Materials and methods
2.1. Cell lines and transfection
2.2. LOX enzyme gene expression
2.3. 12(S)-HETE ELISA
2.4. Compounds
2.5. Cell number and induction of apoptosis
2.6. Calculation of LOX-inhibitory activity
3. Results
3.1. Expression of LOX-enzymes in colorectal tumour cells
3.2. Overexpression of 12(S)-LOX in SW480 cells
3.3. Activity of plant constituents
4. Discussion
Acknowledgements
References





 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.